Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J SMALL

Showing results (1081-1090 of 1,203) with videos related to

Pageof 121
Sort By:
The New England Journal of Medicine|February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate CancerMatthew R Smith, Fred Saad, Simon Chowdhury, et al.
Gastroenterology|April 29, 2015
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaAaron J Small, James L Araujo, Cadman L Leggett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignanciesAmy J Chien, Julie A Illi, Andrew H Ko, et al.
Frontiers in Oncology|April 24, 2023
Somatic alterations of <i>TP53</i> and <i>MDM2</i> associated with response to enfortumab vedotin in patients with advanced urothelial cancerTanya Jindal, Xiaolin Zhu, Rohit Bose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 resultsMichael J Morris, Arturo Molina, Eric J Small, et al.
Psychiatry Research Communications|June 28, 2023
Promoting OCD WEllness and resilience (POWER) study: Rationale, design, and methodsJessica D Leuchter, Minjee Kook, Daniel A Geller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2020
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancerS Halabi, S Dutta, C M Tangen, et al.
JAMA|January 15, 2020
Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical TrialJ Kellogg Parsons, David Zahrieh, James L Mohler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2023
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
Cancer|October 4, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical careLisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland, et al.
Pageof 121

Showing results (1081-1090 of 1,203) with videos related to

Sort By:
Pageof 121
The New England Journal of Medicine|February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate CancerMatthew R Smith, Fred Saad, Simon Chowdhury, et al.
Gastroenterology|April 29, 2015
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaAaron J Small, James L Araujo, Cadman L Leggett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignanciesAmy J Chien, Julie A Illi, Andrew H Ko, et al.
Frontiers in Oncology|April 24, 2023
Somatic alterations of <i>TP53</i> and <i>MDM2</i> associated with response to enfortumab vedotin in patients with advanced urothelial cancerTanya Jindal, Xiaolin Zhu, Rohit Bose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 resultsMichael J Morris, Arturo Molina, Eric J Small, et al.
Psychiatry Research Communications|June 28, 2023
Promoting OCD WEllness and resilience (POWER) study: Rationale, design, and methodsJessica D Leuchter, Minjee Kook, Daniel A Geller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2020
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancerS Halabi, S Dutta, C M Tangen, et al.
JAMA|January 15, 2020
Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical TrialJ Kellogg Parsons, David Zahrieh, James L Mohler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2023
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
Cancer|October 4, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical careLisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland, et al.
Pageof 121